Covid-19 Hastalarının Kan Gazı Ölçümleri ve Hematolojik Manifestasyonlarının Mortalite ile İlişkisi: Retrospektif Analiz
Amaç: Amacımız, COVİD-19’lu hastaların yoğun bakım ünitesine yatış ve sonrası dönemde kan gazı ve tam kan sayımı parametrelerinin mortalite ile ilişkilerini araştırmaktır.
Gereç ve Yöntemler: Hastalar grup yaşamayan ve grup yaşayan olarak iki gruba ayrıldı. Hematolojik parametreler 1, 3, 5. gün kaydedildi.
Bulgular: Yüz kırk iki hasta retrospektif olarak analiz edildi. Bunların 46’sı (%32) kadındı. 71 hasta (%50) yaşamayan gruptaydı. Yaşamayan grupta ortalama yaş 61, yaşayan grupta ortalama yaş 60’tı. Noninvaziv ventilasyon günü ve invaziv ventilasyon günü yaşamayan grupta daha yüksekti. Yaşamayan grupta yoğun bakıma yatışta, 3.günde ve 5.günde PO2/FiO2 (p
Relationship of Blood Gas Measurements and Hematological Manifestations of COVID-19 Patients with Mortality: Retrospective Analysis
Objective: The aim was to investigate the relationship between blood gas and complete blood count parameters and mortality in patients with COVID-19 during and after in the intensive care unit (ICU).
Material and Methods: Patients were divided as group nonsurvivor and group survivor. Hematological parameters were registered on the day 1, 3, 5.
Results: A total of 142 patients were analyzed retrospectively in the study. Out of them, 46 were women (32%). Seventy-one patients were in group nonsurvivor (50%). The median age of group nonsurvivor patients was 61 years, and the median age of group survivor patients was 60 years. Noninvasive ventilation day and mechanical ventilation day were higher in group nonsurvivor. In group nonsurviver, at the admission to the ICU, in the third day and in the fifth day of ICU, PO2/FiO2 (p
___
- World Health Organization. Coronavirus Disease (COVID-19)
Outbreak. https://www.who.int. Accessed January 31, 2022.
- Sun X, Wanga T, Cai D, Hu Z, Chen J, Liao H et al. Cytokine
storm intervention in the early stages of COVID-19 pneumonia.
Cytokine and Growth Factor Rev. 2020;53:38–42.
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course
and risk factors for mortality of adult inpatients with COVID-
19 in Wuhan, China: a retrospective cohort study. Lancet.
2020;395:1054–1062.
- Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H et al. Clinical
and immunological features of severe and moderate coronavirus
disease 2019. J Clin Invest. 2020;130:2620–2629.
- Lippia G, Plebanib M, Henry BM. Thrombocytopenia is associated
with severe coronavirus disease 2019 (COVID-19) infections:
A meta-analysis. Clin Chim Acta. 2020;506:145–148.
- Russell CD, Parajuli A, Gale HJ, Bulteel NS, Schuetz P, de Jager
CPC et al. The utility of peripheral blood leucocyte ratios as biomarkers
in infectious diseases: a systematic review and meta-analysis.
J Infect. 2019;78 (5):339–348.
- Peng J, Qi D, Yuan G, Deng X, Mei Y, Feng L et al. Diagnostic
value of peripheral hematologic markers for coronavirus disease
2019 (COVID-19): A multicenter, cross-sectional study. J. Clin.
Lab. Anal. 2020;34(10): e23475.
- Fois AG, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R
et al. The Systemic Inflammation Index on Admission Predicts
In-Hospital Mortality in COVID-19 Patients. Molecules.
2020;25(23):5725.
- Kucukcan NE, Kucukcan A. The relationship between hemogram
parameters with clinical progress in COVID-19 patients.
Dicle Med J. 2020;47(4):763-769
- Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al. Clinical course and
outcomes of critically ill patients with SARS-CoV-2 pneumonia
in Wuhan, China: A single-centered, retrospective, observational
study. Lancet Respir Med. 2020;8(5):475–481.
Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L et al. Clinical
characteristics of fatal and recovered cases of coronavirus disease
2019 in Wuhan, China: a retrospective study. Chin Med J (Engl).
2020;133(11):1261–1267.
- Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y et al. Dysregulation
of immune response in patients with COVID-19 in Wuhan,
China, Clin Infect Dis. 2020;71(15):762–768.
13. Guan WJ, Ni ZY, Hu Y, W. Liang, C. Ou, J. He et al. Clinical characteristics
of coronavirus disease 2019 in China. N Engl J Med.
2020;382:1708–1720.
- Sun D, Zhang D, Tian R, Li Y, Wang Y, Cao J et al. The underlying
changes and predicting role of peripheral blood inflammatory
cells in severe COVID-19 patients: A sentinel? Clinica Chimica
Acta 2020;508:122–9.
15. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical
Characteristics of 138 Hospitalized Patients With 2019 Novel
Coronavirus–Infected Pneumonia in Wuhan, China. JAMA.
2020;323(11):1061–1069.
- Wu C, Chen X, Cai Y, Xia J, Zhou X, Xue S et al. Risk factors
associated with acute respiratory distress syndrome and death
in patients with coronavirus disease 2019 pneumonia in Wuhan,
China. JAMA Intern Med. 2020;180(7):934–943.
17. Zhang H, Cao X, Kong M, Mao X, Huang L, He P et al. Clinical
and hematological characteristics of 88 patients with COVID-19.
Int J Lab Hematol. 2020;42 (6):780–787.
- Li X, Liu C, Mao Z, Xiao M, Wang L, Qi S et al. Predictive values
of neutrophil-to-lymphocyte ratio on disease severity and
mortality in COVID-19 patients: a systematic review and meta-
analysis. Crit Care. 2020;24(1):647.
- Jenne CN, Kubes P. Platelets in inflammation and infection. Platelets.
2015;26 (4):286-292.
- Qu R, Ling Y, Zhang YH, Wei L, Chen X, Li XM, et al. Platelet-
to-lymphocyte ratio is associated with prognosis in patients
with coronavirus disease-19. J Med Virol. 2020;92(9):1533-1541.
- Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive
role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol.
2020;84:106504.
- Lagunas-Alvarado M, Mijangos-Huesca FJ, Teran-Gonz ´ alez
JO, Alvarado L, Zavala M, Franco R et al. Systemic immune inflammatory
index in sepsis. Med. Int. M´ex. 2017;33(3),303–309.
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan,
China. Lancet. 2020;395 (10223):497–506.